Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model

Cell Cycle

Volumn 10, Issue 9, 2011, Pages 1352-1355

  Azzam, Gregory A ^a   Frank, Amanda K ^a   Hollstein, Monica ^b   Murphy, Maureen E ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Apoptosis; B; Codon 72; NF ; p53; Polymorphism

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53;

APOPTOSIS; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GROWTH; CANCER INHIBITION; CANCER RISK; CODON; DNA POLYMORPHISM; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79955591120     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.9.15344     Document Type: Review

References (28)

1. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303:1010-4. (Pubitemid 38209704)
2. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6:443-50. (Pubitemid 38607505)
3. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11:577-90. (Pubitemid 36385115)
4. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358:80-3.
5. Sherr CJ, Bertwistle D, DENB W, Kuo ML, Sugimoto M, Tago K, et al. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol 2005; 70:129-37. (Pubitemid 44124864)
6. WAF1. Cell Cycle 2005; 4:1264-71.
7. Orsted DD, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival and risk of cancer in the general population. J Exp Med 2007; 204:1295-301. (Pubitemid 46919867)
8. Frank AK, Leu JI, Zhou Y, Devarajan K, Nedelko T, Klein-Szanto A, et al. The Codon 72 Polymorphism of p53 Regulates Interaction with NF{kappa}B and Transactivation of Genes Involved in Immunity and Inflammation. Mol Cell Biol 2011; 31:1201-13.
9. Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33:357-65. (Pubitemid 36278852)
10. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, et al. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 2003; 3:387-402. (Pubitemid 38340307)
11. Zhu F, Dolle ME, Berton TR, Kuiper RV, Capps C, Espejo A, et al. Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res 2010; 70:5851-9.
12. Li X, Dumont P, Della Pietra A, Shetler C, Murphy ME. The codon 47 polymorphism in p53 is functionally significant. J Biol Chem 2005; 280:24245-51. (Pubitemid 40884914)
13. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004; 119:591-602. (Pubitemid 39535748)
14. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer 2009; 9:95-107.
15. Bond GL, Hirshfield KM, Kirchhoff T, Alexe G, Bond EE, Robins H, et al. MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res 2006; 66:5104-10. (Pubitemid 43844932)
16. Almeida LO, Custodio AC, Pinto GR, Santos MJ, Almeida JR, Clara CA, et al. Polymorphisms and DNA methylation of gene Tp53 associated with extraaxial brain tumors. Genet Mol Res 2009; 8:8-18.
17. Pinto GR, Yoshioka FK, Silva RL, Clara CA, Santos MJ, Almeida JR, et al. Prognostic value of Tp53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet Mol Res 2008; 7:207-16. (Pubitemid 351543678)
18. Post SM, Quintas-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, et al. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell 2010; 18:220-30.
19. Reinbold M, Luo JL, Nedelko T, Jerchow B, Murphy ME, Whibley C, et al. Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. Oncogene 2008; 27:2788-94. (Pubitemid 351581466)
20. Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene 2001; 20:320-8. (Pubitemid 32142321)
21. Song H, Hollstein M, Xu Y. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol 2007; 9:573-80. (Pubitemid 46696539)
22. Barre B, Perkins ND. The Skp2 promoter integrates signaling through the NFkappaB, p53 and Akt/ GSK3beta pathways to regulate autophagy and apoptosis. Mol Cell 2010; 38:524-38.
23. Post SM, Quintas-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene 2010; 29:1260-9.
24. Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010; 327:863-6.
25. Seitzer N, Mayr T, Streit S, Ullrich A. A single nucleotide change in the mouse genome accelerates breast cancer progression. Cancer Res 2010; 70:802-12.
26. Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN, Jackson AU, et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 2008; 57:3136-44.
27. Vaji S, Salehi Z, Aminian K. Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran. Int J Colorectal Dis 2011; 26::235-8.
28. Vietri MT, Riegler G, Ursillo A, Caserta L, Cioffi M, Molinari AM. p53 codon 72 polymorphism in patients affected with ulcerative colitis. J Gastroenterol 2007; 42:456-60. (Pubitemid 47050008)